Russell Investments Group
ELOX

Russell Investments Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Russell Investments Group’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-188
Closed -$25K – 3340
2021
Q1 		$25K Hold
188
– – ﹤0.01% 3057
2020
Q4 		$29K Sell
188
-1,568
-89% -$192K ﹤0.01% 2960
2020
Q3 		$184K Buy
+1,756
New +$210K ﹤0.01% 2800

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Russell Investments Group's ELOX Position: Q2 2021 in Review

Russell Investments Group sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 188 shares — an estimated $25K sold.

Russell Investments Group first reported a position in ELOX in Q3 2020 and held it in 3 quarters. The position peaked at $184K in Q3 2020. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

  • Russell Investments Group reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 188 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $25K.
  • Russell Investments Group first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Russell Investments Group's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $184K in Q3 2020.
  • 46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.